Legal status · Australia
Is Navepegritide legal in Australia?
No. Navepegritide is not approved for any medical use in Australia; its classification is "Not yet registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Strong.
Navepegritide in Australia at a glance
| Classification | Not yet registered |
|---|---|
| TGA approval status | Not approved by TGA; investigational |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Navepegritide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
Navepegritide is being studied in registered clinical trials but has not received TGA marketing approval in Australia.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Navepegritide is
A once-weekly prodrug of C-type natriuretic peptide, FDA-approved in February 2026 for achondroplasia in children aged two and older.
Navepegritide releases C-type natriuretic peptide slowly from a carrier, giving a weekly injection that counters the overactive FGFR3 signaling of achondroplasia. 41 on placebo.
Mechanism: Sustained-release CNP analog that stimulates natriuretic peptide receptor B, inhibiting the MAPK pathway downstream of FGFR3 in growth-plate cartilage.
Regulatory history: FDA-approved (accelerated) for achondroplasia, 2026
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Navepegritide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Navepegritide in other countries
Frequently asked questions
Is Navepegritide legal in Australia?
No. Navepegritide is not approved for any medical use in Australia; its classification is "Not yet registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Strong.
Can I buy Navepegritide in Australia?
No approved product exists to buy. In Australia Navepegritide is classified as "Not yet registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Navepegritide TGA approved?
No. In Australia Navepegritide is classified as "Not yet registered", which is not a TGA marketing approval. For comparison, the US FDA status is: FDA-approved (accelerated) for achondroplasia, 2026. Evidence level: Strong.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Navepegritide live on its compound profile.
Navepegritide profileThis page is general information about the regulatory status of Navepegritide in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.